New York State Common Retirement Fund lowered its position in Bath & Body Works, Inc. (NYSE:BBWI – Get Rating) by 0.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC ). The fund owned 290,443 shares of the company’s stock after selling 650 shares during the period. New York State Common Retirement Fund owned approximately 0.12% of Bath & Body Works worth $13,883,000 as of its most recent filing with the Securities and Exchange Commission (SEC ).
Other institutional investors have also added to or reduced their stakes in the company. Caisse DE Depot ET Placement DU Quebec bought a new stake in Bath & Body Works in the fourth quarter worth about $1,431,000. Canada Pension Plan Investment Board lifted its stake in Bath & Body Works by 5.8% in the fourth quarter. Canada Pension Plan Investment Board now owns 564,010 shares of the company’s stock worth $39,362,000 after purchasing an additional 30,900 shares during the last quarter. Loomis Sayles & Co. LP lifted its stake in Bath & Body Works by 17.2% in the fourth quarter. Loomis Sayles & Co. LP now owns 168,282 shares of the company’s stock worth $11,744,000 after purchasing an additional 24,710 shares during the last quarter. Banque Pictet & Cie SA bought a new stake in Bath & Body Works in the fourth quarter worth about $1,802,000. Finally, Kentucky Retirement Systems Insurance Trust Fund lifted its stake in Bath & Body Works by 13.7% in the fourth quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 7,515 shares of the company’s stock worth $524,000 after purchasing an additional 908 shares during the last quarter. Institutional investors own 97.11% of the company’s stock.
Wall Street Analysts Forecast Growth
BBWI has been the subject of several research analyst reports. Cowen decreased their price target on shares of Bath & Body Works from $82.00 to $60.00 in a research note on Friday, May 20th. TheStreet downgraded shares of Bath & Body Works from a “c+” rating to a “d” rating in a research note on Friday, June 3rd. Barclays decreased their price target on shares of Bath & Body Works from $53.00 to $40.00 and set an “equal weight” rating for the company in a research note on Friday , May 20th. UBS Group decreased their price target on shares of Bath & Body Works from $70.00 to $42.00 and set a “buy” rating for the company in a research note on Friday, July 15th. Finally, Telsey Advisory Group decreased their price target on shares of Bath & Body Works from $60.00 to $40.00 and set an “outperform” rating for the company in a research note on Thursday, July 21st. Four investment analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has assigned a strong b uy rating to the company. Based on data from MarketBeat, Bath & Body Works has an average rating of “Moderate Buy” and a consensus price target of $49.90.
Insider Activity
In other news, insider Thomas E. Mazurek sold 16,338 shares of the business’s stock in a transaction on Friday, May 27th. The shares were sold at an average price of $42.25, for a total transaction of $690,280.50. Following the sale, the insider now directly owns 11,225 shares of the company’s stock, valued at $474,256.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.37% of the company’s stock.
Bath & Body Works Trading Down 2.8%
NYSE BBWI opened at $37.36 on Friday. The firm’s fifty day simple moving average is $32.76 and its two-hundred day simple moving average is $44.66. Bath & Body Works, Inc. has a 12-month low of $25.75 and a 12-month high of $82.00. The firm has a market capitalization of $8.55 billion, a P/E ratio of 8.14, a P/E/G ratio of 3.73 and a beta of 1.82.
Bath & Body Works (NYSE:BBWI – Get Rating) last released its quarterly earnings results on Wednesday, May 18th. The company reported $0.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.51 by $0.13. Bath & Body Works had a net margin of 15.41% and a negative return on equity of 69.03%. The business had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.43 billion. As a group, sell-side analysts predict that Bath & Body Works, Inc. will post 2.64 earnings per share for the current fiscal year.
Bath & Body Works Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, June 17th. Stockholders of record on Friday, June 3rd were issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.14 %. The ex-dividend date was Thursday, June 2nd. Bath & Body Works’s dividend payout ratio (DPR) is presently 17.43%.
Bath & Body Works Profile
(Get Rating)
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
Read More
Receive News & Ratings for Bath & Body Works Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Bath & Body Works and related companies with MarketBeat.com’s FREE daily email newsletter.